Sign in

You're signed outSign in or to get full access.

Margaret L. Wolff

About Margaret L. Wolff

Margaret L. Wolff is an Independent Board Member of the Nuveen fund complex (including Nuveen Quality Municipal Income Fund, NAD), with board service since 2016. She is a retired Skadden, Arps, Slate, Meagher & Flom LLP M&A lawyer (Of Counsel 2005–2014) with 30+ years advising boards and senior management on corporate, securities, governance and fiduciary matters; she holds a B.A. from Mt. Holyoke College and a J.D. from Case Western Reserve University School of Law, and was born in 1955 .

Past Roles

OrganizationRoleTenureCommittees/Impact
Skadden, Arps, Slate, Meagher & Flom LLPM&A Group; Of Counsel2005–2014 (retired 2014); 30+ years totalAdvised boards and senior management on governance, shareholder, fiduciary, regulatory and strategic matters
Mt. Holyoke CollegeTrustee; Vice Chair of BoardTrustee 2005–2015; Vice Chair 2011–2015Higher-education governance leadership

External Roles

OrganizationRoleTenureNotes
New York-Presbyterian HospitalTrusteeSince 2005Major nonprofit healthcare system governance
The John A. Hartford FoundationTrustee; former ChairTrustee since 2004; Chair 2015–2022Philanthropy focused on care for older adults
Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (Travelers Canada)Director2013–2017Canadian operations of The Travelers Companies

Board Governance

  • Independence: Serves as an Independent Board Member; all Audit Committee members are independent under NYSE/NASDAQ and SEC standards .
  • Committee assignments (current):
    • Compliance, Risk Management and Regulatory Oversight Committee: Chair .
    • Audit Committee: Member (Chair is John K. Nelson; designated “financial experts” are Boateng, Nelson, Starr, Young) .
    • Closed-End Fund Committee: Member .
  • Attendance: Each Board Member attended 75% or more of Board and relevant committee meetings in the last fiscal year .
  • Board tenure structure: Boards are classified (I/II/III) with three-year terms for common-share elected members; Wolff is a continuing Board Member with class designations rotating by fund (e.g., Class III through 2025 for certain funds) .

Fixed Compensation

Compensation is cash-based retainers and fees, with optional deferred compensation; there are no equity grants for directors disclosed.

Component2022202320242025
Annual Retainer (Independent Board Member)$205,000 $210,000 $350,000 $350,000
Audit Committee Member RetainerPer-meeting $2,500/$2,250 (attendance-based) Per-meeting $2,500 $30,000 annual $35,000 annual
Compliance Committee Member RetainerPer-meeting $5,000/$2,000 (attendance-based) Per-meeting $5,000 $30,000 annual $35,000 annual
Investment Committee Member RetainerPer-meeting $2,500 Per-meeting $2,500 $20,000 annual $30,000 annual
Dividend Committee Member RetainerPer-meeting $1,250 Per-meeting $1,250 $20,000 annual $25,000 annual
Nominating & Governance Member Retainer$500 per meeting $500 per meeting $20,000 annual $25,000 annual
Closed-End Funds Committee Member RetainerPer-meeting $2,500/$2,000 Per-meeting $2,500 $20,000 annual $25,000 annual
Board Chair Retainer$125,000 $140,000 $140,000 $150,000
Audit Committee Chair Retainer$20,000 $20,000 $30,000 $35,000
Compliance Committee Chair Retainer$20,000 $20,000 $30,000 $35,000
Investment Committee Chair/Co-Chair Retainer$20,000 $20,000 $20,000 $30,000
Dividend/Nominating/Closed-End Chair Retainer$20,000 each $20,000 each $20,000 each $25,000 each
Ad hoc meeting fees$1,000/$500 depending on format $1,000/$500; site visits $5,000/day $1,000 or $2,500 per ad hoc; special assignment members $5,000/qtr $1,000 or $2,500 per ad hoc; special assignment members $5,000/qtr

Additional disclosure: Total compensation from Nuveen funds in 2021–2022 for each Independent Board Member is tabulated; Wolff’s total was $425,836 (includes deferred fees) for the last fiscal year in that table .

Performance Compensation

ItemDisclosure
Equity awards (RSUs/PSUs)None disclosed for Independent Board Members .
OptionsNone disclosed for Independent Board Members .
Deferred Compensation PlanOptional; credits to a book reserve account tracking eligible Nuveen funds; distributions may be lump sum or over 2–20 years; fund not liable for other funds’ obligations .
Retirement/PensionFunds do not have retirement or pension plans for directors .
Clawbacks/COC/SeveranceNot disclosed/applicable to Independent Board Members in proxy .

Other Directorships & Interlocks

Company/InstitutionRoleDatesPotential Interlocks/Notes
New York-Presbyterian HospitalTrusteeSince 2005Nonprofit; no advisory interlock to Nuveen/TIAA disclosed .
The John A. Hartford FoundationTrustee; former ChairTrustee since 2004; Chair 2015–2022Philanthropy; no fund adviser interlock disclosed .
Travelers Canada (Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company)Director2013–2017No conflict with NAD’s municipal focus disclosed .

Expertise & Qualifications

  • Corporate/M&A legal expertise with extensive board advisory experience on governance, fiduciary duties, regulatory and strategic issues .
  • Nonprofit board leadership (healthcare and elder care philanthropy) and higher education governance .
  • Not designated as an SEC “audit committee financial expert” (designation applies to Boateng, Nelson, Starr, Young) .

Equity Ownership

Measure202320242025
NAD (Quality Income) shares directly/indirectly owned by Wolff0 0 0
Aggregate dollar range across all Nuveen registered investment companies overseenOver $100,000 Over $100,000 Over $100,000
Board principle: expected to invest at least one year of compensation in Nuveen fundsPolicy disclosedPolicy disclosedPolicy disclosed
CitationBoard investment principle: “each Board Member is expected to invest, either directly or on a deferred basis, at least the equivalent of one year of compensation”

Notes: As of the relevant measurement dates, Board Members and officers as a group owned less than 1% of outstanding shares of each fund; individual director holdings in each fund were less than 1% .

Governance Assessment

  • Strengths

    • Chair of the Compliance, Risk Management and Regulatory Oversight Committee, indicating active oversight of compliance, liquidity/derivatives usage, leverage, operational risk, and regulatory matters; receives regular reports and meets privately with the CCO quarterly .
    • Independent director with consistent committee service (Audit; Closed-End Fund) and attendance at or above the 75% threshold in the last fiscal year .
    • Deep governance and fiduciary advisory background from a top-tier M&A legal practice; extensive experience advising boards and senior management .
  • Potential alignment/compensation signals

    • Compensation shifted materially from per-meeting fees (2022–2023) to large fixed annual retainers beginning 2024, with further increases in 2025 at the committee and chair level; fixed cash emphasis may reduce direct performance linkage, though an expectation exists to invest at least one year’s compensation in Nuveen funds .
    • No equity or option awards for Independent Board Members are disclosed; alignment is primarily via optional deferred compensation tracking fund NAVs and the board investment principle rather than equity grants .
  • RED FLAGS and conflicts

    • No related-party transactions or director holdings in adviser-controlled private entities are disclosed for Wolff; the only such disclosure in the proxy relates to another director (Kenny), not Wolff .
    • Wolff’s direct ownership in NAD is zero as of May 31, 2023–2025; while the aggregate across the family is “Over $100,000,” lack of fund-specific stake in NAD could be viewed as a weaker fund-level alignment signal relative to peers who hold NAD shares .
    • Not designated as an “audit committee financial expert,” though she serves on the Audit Committee; the committee includes multiple designated financial experts .

Overall, Wolff presents as a seasoned, independent governance professional with meaningful compliance leadership and strong attendance. Compensation modernization to fixed retainers increases predictability but reduces at-risk/performance-based elements; alignment relies on the deferred plan and the board’s investment principle rather than fund-specific ownership (NAD holding currently zero) .